These studies suggested that oral administration of Bifidobacterium in mice can affect the immune microenvironment of glioma, including induction of DC maturation, stimulation of tumor-specific CD8+T cells, recruitment of other immune cells, and activation of type I interferon signal, which hinder tumor growth (137). The gene discussed is CD8A; the disease is glioma.